Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment for Advanced Pancreatic Cancer
This open-label, single-arm, pilot, phase 1b/2 clinical trial assesses outcomes following treatment with nab-paclitaxel plus gemcitabine plus the platinum-based cisplatin for patients with previously untreated metastatic pancreatic ductal adenocarcinoma.